Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Suzhou Zelgen Biopharmaceuticals Co., Ltd.verified

688266.SS

Price:

$94.51

Market Cap:

$25.02B

Suzhou Zelgen Biopharmaceuticals Co., Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers small molecule and recombinant protein drugs for the treatment of liver cancer, non-small cell lung cancer, colorectal cancer, thyroid cancer, nasopharyngeal carcinomas, myelofibrosis, hemorrhage, and hepatobiliary diseases. The company was founded in 2009 and is based in Kunshan, the People's Republic of China.

Industry

Biotechnology

IPO Date

2020-01-23

Stock Exchange

SHH

Ticker

688266.SS

The PE Ratio as of November 2025 (TTM) for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) is -189.02

According to Suzhou Zelgen Biopharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -189.02. This represents a change of 20.32% compared to the average of -157.10 of the last 4 quarters.

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) Historical PE Ratio (quarterly & annually)

How has 688266.SS PE Ratio performed in the past?

The mean historical PE Ratio of Suzhou Zelgen Biopharmaceuticals Co., Ltd. over the last ten years is -59.55. The current -189.02 PE Ratio has changed 31.64% with respect to the historical average. Over the past ten years (40 quarters), 688266.SS's PE Ratio was at its highest in in the December 2018 quarter at -9.58. The PE Ratio was at its lowest in in the March 2025 quarter at -226.68.

Quarterly (TTM)
Annual

Average

-59.55

Median

-48.63

Minimum

-119.83

Maximum

-21.88

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Suzhou Zelgen Biopharmaceuticals Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 144.41%

Maximum Annual PE Ratio = -21.88

Minimum Annual Increase = -66.72%

Minimum Annual PE Ratio = -119.83

Quarterly (TTM)
Annual
YearPE RatioChange
2024-119.83144.41%
2023-49.03124.04%
2022-21.88-30.06%
2021-31.29-35.66%
2020-48.6325.48%
2019-38.7627.24%
2018-30.46-66.72%
2017-91.52-12.43%

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) Average PE Ratio

How has 688266.SS PE Ratio performed in the past?

The current PE Ratio of Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-63.58

5-year avg

-54.13

10-year avg

-59.55

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) PE Ratio vs. Peers

How is 688266.SS’s PE Ratio compared to its peers?

Suzhou Zelgen Biopharmaceuticals Co., Ltd.’s PE Ratio is less than Shijiazhuang Yiling Pharmaceutical Co., Ltd. (-53.36), less than Hualan Biological Engineering Inc. (25.83), less than Xiamen Amoytop Biotech Co., Ltd. (31.30), greater than Sinocelltech Group Limited (-516.27), less than Asymchem Laboratories (Tianjin) Co., Ltd. (31.67), less than Staidson (Beijing) BioPharmaceuticals Co., Ltd. (-98.00), less than Zhejiang Huahai Pharmaceutical Co., Ltd. (34.87), less than Shanghai Junshi Biosciences Co., Ltd. (-35.59), less than Kangmei Pharmaceutical Co., Ltd. (3.02K), less than DaShenLin Pharmaceutical Group Co., Ltd. (19.93),

Build a custom stock screener for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Suzhou Zelgen Biopharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Suzhou Zelgen Biopharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Suzhou Zelgen Biopharmaceuticals Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)?

What is the highest PE Ratio for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)?

What is the 3-year average PE Ratio for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)?

What is the 5-year average PE Ratio for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS)?

How does the current PE Ratio for Suzhou Zelgen Biopharmaceuticals Co., Ltd. (688266.SS) compare to its historical average?